Total Revenue
Abbott Total Revenue decreased by 2.6% to $11.16B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $10.36B to $11.16B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows relatively stable performance with a 0.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.22B | $10.93B | $11.47B | $11.90B | $11.26B | $10.41B | $10.09B | $9.75B | $9.98B | $10.14B | $10.24B | $9.96B | $10.38B | $10.64B | $10.97B | $10.36B | $11.14B | $11.37B | $11.46B | $11.16B |
| QoQ Change | — | +6.9% | +4.9% | +3.7% | -5.4% | -7.5% | -3.1% | -3.4% | +2.4% | +1.7% | +1.0% | -2.7% | +4.1% | +2.5% | +3.2% | -5.6% | +7.6% | +2.0% | +0.8% | -2.6% |
| YoY Change | — | — | — | — | +10.1% | -4.7% | -12.0% | -18.1% | -11.4% | -2.6% | +1.5% | +2.2% | +4.0% | +4.9% | +7.2% | +4.0% | +7.4% | +6.9% | +4.4% | +7.8% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $4.73B | $4.75B | $5.05B | $4.90B | $5.37B | $5.45B | $5.68B | $5.54B |
| Diagnostic Products | $2.20B | $2.41B | $2.52B | $2.05B | $2.17B | $2.25B | $2.46B | $2.18B |
| Nutritional Products | $2.15B | $2.07B | $2.13B | $2.15B | $2.21B | $2.15B | $1.94B | $2.02B |
| Established Pharmaceuticals | $1.29B | $1.41B | $1.27B | $1.26B | $1.38B | $1.51B | $1.38B | $1.43B |
| Total | $10.38B | $10.64B | $10.97B | $10.36B | $11.14B | $11.37B | $11.46B | $11.16B |
Geographic Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| International | $6.44B | $6.43B | $6.63B | $6.19B | $6.87B | $7.07B | $7.08B | $6.89B |
| Total | $10.38B | $10.64B | $10.97B | $10.36B | $11.14B | $11.37B | $11.46B | $11.16B |
Total Revenue at Other Companies
Frequently Asked Questions
- What is Abbott's total revenue?
- Abbott (ABT) reported total revenue of $11.16B in Q1 2026.
- How has Abbott's total revenue changed year-over-year?
- Abbott's total revenue increased by 7.8% year-over-year, from $10.36B to $11.16B.
- What is the long-term trend for Abbott's total revenue?
- Over 4 years (2021 to 2025), Abbott's total revenue has grown at a 0.7% compound annual growth rate (CAGR), from $43.08B to $44.33B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.